OncoSynergy Competitors and Similar CompaniesClear all
Biocon's competitors and similar companies include Allogene Therapeutics.
 Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | ||
Founding Date | Founding Date 1978 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations South San Francisco, US HQ |
Employees | Employees 16,5612% increase | Employees 2263% decrease |
Financial | ||
Net income | Net income ₹3.7b (FY, 2026) | Net income ($190.9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Allogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company